Anika Therapeutics (NSDQ:ANIK) has inked an agreement with the Institute of Integrative Biology at the University of Liverpool to develop an injectable mesenchymal stem cell therapy to treat osteoarthritis. As a result of the three-year research collaboration, the group hopes to have a lead candidate that it can take into clinical trials. Get the full story at our […]
University of Liverpool
Study: Nanotechnology could cut dose of HIV treatment in half
Researchers from the University of Liverpool presented data this week evaluating the use of nanotechnology to improve drug therapies for HIV patients. The team touted its data at the Conference on Retroviruses and Opportunistic Infections in Seattle. The trial enrolled healthy patients and evaluated the use of orally-dosed solid drug nanoparticles to optimize HIV therapy, according […]
Solid drug nanoparticles could improve delivery of HIV therapies
Researchers from the University of Liverpool have developed a method of delivering pediatric HIV drugs using solid drug nanoparticles, according to a study published today in Nature Communications. There are no clinically available oral nanotherapies for HIV patients and pediatric HIV medicines are not widely available, according to the researchers. The team examined a current pediatric […]
